SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anupam Rasayan India informs about allotment under ESOP

04 Sep 2023 Evaluate
Anupam Rasayan India has informed that the Nomination and Remuneration Committee (NRC) of the Board of Directors of the Company at its meeting held on September 04, 2023, has approved the issue and allotment of 66,385 (Sixty-Six Thousand Three Hundred and Eighty Five) fully paid-up equity shares of face value of INR 10 each under Anupam - Employees Stock Option Plan 2020 of the Company pursuant to exercise of Options by the eligible employees. The equity shares so allotted under the Scheme shall rank pari-passu with the existing equity shares of the Company in all respects including dividend. Further, it informed that the Company has obtained the necessary in-principle approvals from BSE Limited and National Stock Exchange of India in respect of total 13,12,795 equity shares (which forms the ESOP scheme size) which shall be issued by the Company from time to time on vesting and exercise of the same under the ESOP Scheme 2020. Post allotment, the issued, subscribed and paid up share capital of the Company shall stand increased from INR 1,07,53,88,640 (Indian Rupees One Hundred and Seven Crores Fifty Three Lakhs Eighty Eight Thousand Six Hundred and Forty Only) comprising of 10,75,38,864 (Ten Crores Seventy Five Lakhs Thirty Eight Thousand Eight Hundred and Sixty Four) equity shares of INR 10 (Indian Rupees Ten only) each fully paid up to INR 1,07,60,52,490 (Indian Rupees One Hundred and Seven Crores Sixty Lakhs Fifty Two Thousand Four Hundred and Ninety Only) comprising of 10,76,05,249 (Ten Crores Seventy Six Lakhs Five Thousand Two Hundred and Forty Nine) equity shares of INR 10 (Indian Rupees Ten only) each fully paid up.

 above information is a part of company’s filings submitted to BSE.

Anupam Rasayan India Share Price

1318.35 9.30 (0.71%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3693.20
Tata Chemicals 707.70
SRF 2474.05
Pidilite Inds. 1407.65
Deepak Nitrite 1645.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×